JAZZ FY 2010 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$174M+35.3% YoY

Gross Profit

$160M92.2% margin

Operating Income

$58M33.3% margin

Net Income

$33M18.9% margin

EPS (Diluted)

$0.83

Cash Flow

Operating Cash Flow

$59M

Free Cash Flow

$54M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$136M

Total Liabilities

$105M

Stockholders' Equity

$31M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174M	$128M	+35.3%
Gross Profit	$160M	$119M	+34.9%
Operating Income	$58M	$16M	+262.8%
Net Income	$33M	-$7M	+579.5%